Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 2080, 2020 02 07.
Artigo em Inglês | MEDLINE | ID: mdl-32034188

RESUMO

The causes of infections in pediatric populations differ between age groups and settings, particularly in the tropics. Such differences in epidemiology may lead to misdiagnosis and ineffective empirical treatment. Here, we investigated the current spectrum of pathogens causing febrile diseases leading to pediatric hospitalization in Lambaréné, Gabon. From August 2015 to March 2016, we conducted a prospective, cross-sectional, hospital-based study in a provincial hospital. Patients were children ≤ 15 years with fever ≥ 38 °C and required hospitalization. A total of 600 febrile patients were enrolled. Malaria was the main diagnosis found in 52% (311/600) patients. Blood cultures revealed septicemia in 3% (17/593), among them four cases of typhoid fever. The other causes of fever were heterogeneously distributed between both bacteria and viruses. Severe infections identified by Lambaréné Organ Dysfunction Score (LODS) were also most often caused by malaria, but children with danger signs did not have more coinfections than others. In 6% (35/600) of patients, no pathogen was isolated. In Gabon, malaria is still the major cause of fever in children, followed by a bacterial and viral disease. Guidelines for both diagnosis and management should be tailored to the spectrum of pathogens and resources available locally.


Assuntos
Febre/etiologia , Infecções/complicações , Criança , Pré-Escolar , Estudos Transversais , Feminino , Gabão/epidemiologia , Hospitais/estatística & dados numéricos , Humanos , Lactente , Infecções/epidemiologia , Infecções/microbiologia , Infecções/virologia , Malária/complicações , Malária/epidemiologia , Masculino , Escores de Disfunção Orgânica , Estudos Prospectivos , Sepse/complicações , Sepse/epidemiologia , Febre Tifoide/complicações , Febre Tifoide/epidemiologia
2.
J Infect Dis ; 205(11): 1745-56, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22457278

RESUMO

BACKGROUND: Mu opioid receptor (OPRM1) ligands may alter expression of chemokines and chemokine receptors involved in penetration of human immunodeficiency virus (HIV) type 1 into the cell. We suggest that OPRM1 variants may affect the pathophysiology of HIV infection. METHODS: DNA samples from 1031 eligible African Americans, Hispanics, and whites from the Women's Interagency HIV Study (WIHS) who were alive as of April 2006 were analyzed. We performed regression analysis of association of 18 OPRM1 variants with a change of viral load and CD4 cell count during 2 periods: between admission to WIHS and the start of highly active antiretroviral therapy (HAART) (interval X) and between the start of HAART and the most recent WIHS visit (interval Y), and examined the association of these variants with HIV status. RESULTS: Regardless of genotype, a significant decrease in viral load during interval X was found for each ethnicity. Whites with allele G of the functional polymorphism 118A > G (reference sequence rs1799971) showed a smaller decrease in viral load; those bearing minor alleles IVS1 + 1050A, IVS1 + 14123A, and IVS2 + 31A showed a larger decrease in viral load over interval X (0.01 < P < .05). Hispanics with the same alleles showed a greater increase in CD4 cell count over interval Y (0.01 < P < .05). We found an association between OPRM1 variants and HIV status in African Americans and whites. CONCLUSIONS: OPRM1 polymorphisms may alter the severity of HIV infection before and after HAART.


Assuntos
Infecções por HIV/genética , HIV-1/isolamento & purificação , Polimorfismo Genético , Receptores Opioides mu/genética , Carga Viral , Negro ou Afro-Americano , Fármacos Anti-HIV/administração & dosagem , Terapia Antirretroviral de Alta Atividade , Contagem de Linfócito CD4 , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/patologia , Hispânico ou Latino , Humanos , Índice de Gravidade de Doença , Resultado do Tratamento , População Branca
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...